# Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY).

> **NCT04378855** · — · ACTIVE_NOT_RECRUITING · sponsor: **Gruppo Italiano Malattie EMatologiche dell'Adulto** · enrollment: 572 (actual)

## Conditions studied

- Myeloproliferative Neoplasm

## Interventions

- **OTHER:** Questionnaire

## Key facts

- **NCT ID:** NCT04378855
- **Lead sponsor:** Gruppo Italiano Malattie EMatologiche dell'Adulto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-05-29
- **Primary completion:** 2023-11-15
- **Final completion:** 2025-11-15
- **Target enrollment:** 572 (ACTUAL)
- **Last updated:** 2025-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04378855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04378855, "Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY).". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT04378855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*